The conventional wisdom—and certainly the impression made by much media and advertising—is that CBD is legal pursuant to the federal Farm Bill enacted late last year. As is often the case, however, there are some devils in the details.
In a strange paradox, Turkey's increasingly authoritarian President Erdogan has announced that he wants to expand legal cannabis cultivation in the country. His speech unveiling the proposal even portrayed the plant's prohibition as imposed by Western powers to undermine Turkish agriculture—appealing to his traditional Islamist base, with otherwise conservative instincts.
A House bill to legalize cannabis, removing it from the Controlled Substances Act and treating it like alcohol, is wryly dubbed HR 420. It isn't the first such bill in Congress—but with the recent change in House leadership, this time it may actually stand a chance of passing.
A Chinese delegation to Israel to explore cooperation in the cannabis sector points to the East Asian giant's growing footprint in the global industry. But in a continued contradiction, the People's Republic has possibly the harshest drug laws on Earth—and, where unsanctioned use by the commoners is concerned, cannabis is no exception.
With passage of the Farm Bill and removal of hemp-derived CBD from controlled substance status, big market growth is expected for the very chic and purportedly salubrious non-psychoactive cannabinoid. The law is a win for a nascent CBD industry that has been struggling to shake off the lingering stigma surrounding (psychoactive) cannabis. The effort to segment cannabidiol from "marijuana" is exemplified in the several states that now have "CBD-only" laws.
The newly enacted Farm Bill contains language implicitly removing hemp-derived CBD from the controlled substances list, along with industrial hemp. A CBD industry that has been growing fast in a legal grey zone stands to grow faster in the light of legal clarity. Conflicting state laws and even federal regulations, however, could prove an obstacle to unfettered expansion.
Amid the seemingly endless hype about CBD, its once better-known sibling cannabinoid THC seems to increasingly languish in the shadows—both in terms of media attention and industry investment.
Recent comments
10 weeks 2 days ago
12 weeks 3 days ago
13 weeks 3 days ago
22 weeks 7 hours ago
45 weeks 5 days ago
1 year 8 weeks ago
1 year 16 weeks ago
1 year 16 weeks ago
1 year 18 weeks ago
1 year 22 weeks ago